Kura Oncology, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KURA research report →
Companykuraoncology.com
Kura Oncology, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer.
- CEO
- Troy Edward Wilson
- IPO
- 2015
- Employees
- 192
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $917.93M
- P/E
- -3.11
- P/S
- 12.81
- P/B
- 8.49
- EV/EBITDA
- -3.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 94.66%
- Op Margin
- -443.54%
- Net Margin
- -411.19%
- ROE
- -141.95%
- ROIC
- -57.53%
Growth & Income
- Revenue
- $67.48M · 25.24%
- Net Income
- $-278,666,000 · -60.17%
- EPS
- $-3.18 · -57.43%
- Op Income
- $-303,631,000
- FCF YoY
- -152.82%
Performance & Tape
- 52W High
- $12.49
- 52W Low
- $5.45
- 50D MA
- $8.91
- 200D MA
- $9.10
- Beta
- 0.32
- Avg Volume
- 1.66M
Get TickerSpark's AI analysis on KURA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | Powl Brian T. | sell | 339 |
| May 19, 26 | FORD KATHLEEN | sell | 2,257 |
| May 18, 26 | Bair Teresa Brophy | sell | 2,256 |
| Mar 23, 26 | WILSON TROY EDWARD | other | 6,103 |
| Mar 23, 26 | WILSON TROY EDWARD | other | 6,103 |
| Mar 18, 26 | Malley Thomas | other | 10,000 |
| Mar 18, 26 | Malley Thomas | other | 10,000 |
| Jan 27, 26 | Powl Brian T. | sell | 4,842 |
| Jan 27, 26 | Powl Brian T. | sell | 1,572 |
| Jan 27, 26 | FORD KATHLEEN | sell | 1,813 |
Our KURA Coverage
We haven't published any research on KURA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KURA Report →